Pharmaceutical insurance and the demand for prescription pharmaceuticals in Västerbotten, Sweden

Scandinavian Journal of Public Health

Volumn 33, Issue 1, 2005, Pages 50-56

  Rudholm, Niklas ^a  

^a UMEÅ UNIVERSITY   (Sweden)

Author keywords

pharmaceutical consumption; pharmaceutical insurance

Indexed keywords

ARTICLE; CONSUMER; DRUG COST; DRUG INFORMATION; DRUG MARKETING; DRUG USE; FEMALE; HEALTH CARE SYSTEM; HEALTH INSURANCE; HUMAN; MALE; PATIENT INFORMATION; PHARMACEUTICAL CARE; PRESCRIPTION; PRIORITY JOURNAL; REGRESSION ANALYSIS; REIMBURSEMENT; SWEDEN;

ADOLESCENT; ADULT; AGED; COST SAVINGS; DRUG COSTS; DRUG UTILIZATION; FEES, PHARMACEUTICAL; FEMALE; HUMANS; INSURANCE, PHARMACEUTICAL SERVICES; MALE; MIDDLE AGED; PRESCRIPTIONS, DRUG; REGRESSION ANALYSIS; SWEDEN;

EID: 14244258277     PISSN: 14034948     EISSN: None     Source Type: Journal    
DOI: 10.1080/14034940410028325     Document Type: Article

References (8)

1. Dukes M.N.D., editor. Drug utilization studies. Copenhagen: World Health Organization, 1993.
2. Lundin D. Moral hazard in physician prescription behavior. J Health Econ 2000;19:639-662.
3. Coulson N.E., Stuart B.C. Insurance choice and the demand for prescription drugs. South Econ J 1995;61:1146-1157.
4. Coulson N.E., Terza J.V., Neslusan C.A., Stuart B.C. Estimating the moral-hazard effect of supplemental medical insurance in the demand for prescription drugs by the elderly. Am Econ Rev 1995;85:122-7.
5. Hellerstein J.K. The importance of the physician in the generic versus trade-name prescription decision. Rand J Econ 1998;29:108-136.
6. Maddala G.S. Introduction to econometrics. 3rd ed. Chichester: Wiley, 2001.
7. White H. A heteroskedastic-consistent covariance matrix estimator and a direct test for heteroskedasticity. Econometrica 1980;48:817-838.
8. Strom B.L., editor. Pharmacoepidemiology. 3rd ed. Chichester: Wiley, 2000.